A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
Clinical trial NCT05888493 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05888493
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-02
- Primary completion
- 2028-07-25
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.